Marex Group Limited Ordinary Shares vs Stryker Corporation — how do they compare? Marex Group Limited Ordinary Shares trades at $71.79 (market cap $5.12B), while Stryker Corporation trades at $277.34 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 20.8× Marex Group Limited Ordinary Shares's market cap, and Stryker Corporation pays the higher dividend (1.27%). Which is the better fit depends on your goals — on Pluang, investors hold Marex Group Limited Ordinary Shares for 1 Days and Stryker Corporation for 21 Days on average.
| MRX | SYK | |
|---|---|---|
Market Cap | $5.12B | $106.24B |
Volume | 647,370 | 2,982,001 |
Sector | Financials | Health |
52-Week High | $78.27 | $388.35 |
52-Week Low | $29.92 | $269.75 |
Typical Hold Time | 1 Days | 21 Days |
Enterprise Value | $8.20B | $117.70B |
Dividend Yield | 0.9% | 1.27% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Stryker (SYK) trades at $277.52, up 0.77% today, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279. Fundamentally, the company reported strong profitability with a 14.43% net income margin in 2026 and beat EPS estimates in two of the last three quarters. However, recent news highlights potential legal and manufacturing issues that have pressured investor sentiment.
The outlook is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities lie in SYK's robust earnings growth and market leadership in medical technology, but risks include ongoing legal investigations and persistent manufacturing challenges that could impact future performance.
Trailing returns across standard periods
Latest headlines on both assets
Marex Group provides financial services across commodities, financial markets, and corporate clients. Its services include clearing, agency and execution, market making, hedging, and securities services.
Read more on MRX →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →